Candela to Remain Independent
Candela Corp. has released second quarter results. Revenues totaled $28.8 million, a decrease of 19 percent compared to the $35.7 million reported last year, but […]
Blog
Aethlon Medical to Study Hemopurifier in HIV Treatment
Aethlon Medical is nearing completion of the “first-in-man” study of a medical device to treat HIV; an HIV-infected individual has initiated treatment with the company’s […]
Top 10 Medical Innovations for 2009
The Cleveland Clinic has unveiled its latest Top 10 Medical Innovations list, highlighting technologies that are expected to have a big impact in 2009. Announced […]
Cynosure Revenues Fall, Disappointing But Not Unexpected
Cynosure released preliminary fourth quarter results this week: the company expects revenues of $25 million to $26 million; in the same quarter last year, Cynosure […]
Arbios Systems’ SEPET Going to the Highest Bidder
In August, Arbios Systems suspended operations and laid-off employees as it tried – unsuccessfully – to raise capital. The company has now filed for bankruptcy […]
First CTO Crossing with Stereotaxis’ RF PowerAssert Magnetic Guidewire
The first crossing of a chronic total occlusion (CTO) using Stereotaxis’ RF PowerAssert Magnetic Guidewire occurred this week. PowerAssert, FDA cleared in 2008, is the […]
OneMedForum Now Streaming Live!
I encourage everyone to check out the live broadcast of the OneMedForum, taking place today and tomorrow, 8AM – 5PM PST! The OneMedForum highlights the […]
Insight Dx Prostate Profile: Clarient Launches Gene Expression Test for Prostate Cancer
Clarient has launched a new gene expression diagnostic for prostate cancer, the Insight Dx Prostate Profile (Insight). The test, developed in conjunction with Health Discovery […]
World Heart Submits IDE Application for Levacor VAD
World Heart Corporation has submitted an FDA Investigational Device Exemption application for a pivotal bridge-to-transplant study of its Levacor Ventricular Assist Device (VAD). Ventricular assist […]
[Quick Take] Interview with Tom Bjerg Lauritzen, President & CEO of Vivostat
The Vivostat System is an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin (PRF). It incorporates a […]